Terms: = Liver cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
217 results:
1. A machine-learning model based on dynamic contrast-enhanced MRI for preoperative differentiation between hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma.
Deng X; Liao Z
Clin Radiol; 2024 Jun; 79(6):e817-e825. PubMed ID: 38413354
[TBL] [Abstract] [Full Text] [Related]
2. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
3. Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.
Zhu Y; Tang S; Yuan Q; Fu J; He J; Liu Z; Zhao X; Li Y; Zhao Y; Zhang Y; Zhang X; Zhang Y; Zhu Y; Wang W; Zheng B; Wu R; Wu T; Yang S; Qiu X; Shen S; Hu J; Chen L; Wang Y; Wang H; Gao D; Chen L
Cell Rep Med; 2024 Feb; 5(2):101375. PubMed ID: 38278146
[TBL] [Abstract] [Full Text] [Related]
4. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
5. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
6. Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.
Zheng L; Zhang X; Nian Y; Zhou W; Li D; Wu Y
BMC Gastroenterol; 2023 Nov; 23(1):386. PubMed ID: 37951862
[TBL] [Abstract] [Full Text] [Related]
7. Yttrium-90 Transarterial Radioembolization of Primary Lung cancer Metastases to the liver.
Alexander ES; Petre EN; Zhao K; Sotirchos V; Namakydoust A; Moussa A; Yuan G; Sofocleous CT; Solomon SB; Ziv E
J Vasc Interv Radiol; 2024 Feb; 35(2):214-225.e2. PubMed ID: 37923172
[TBL] [Abstract] [Full Text] [Related]
8. Associations of non-alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1913. PubMed ID: 37840448
[TBL] [Abstract] [Full Text] [Related]
9. Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.
Tharmaseelan H; Vellala AK; Hertel A; Tollens F; Rotkopf LT; Rink J; Woźnicki P; Ayx I; Bartling S; Nörenberg D; Schoenberg SO; Froelich MF
Cancer Imaging; 2023 Oct; 23(1):95. PubMed ID: 37798797
[TBL] [Abstract] [Full Text] [Related]
10. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
[TBL] [Abstract] [Full Text] [Related]
11. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications.
Krajnović M; Kožik B; Božović A; Jovanović-Ćupić S
Cells; 2023 Sep; 12(18):. PubMed ID: 37759525
[TBL] [Abstract] [Full Text] [Related]
12. Natural history study of patients with familial platelet disorder with associated myeloid malignancy.
Cunningham L; Merguerian M; Calvo KR; Davis J; Deuitch NT; Dulau-Florea A; Patel N; Yu K; Sacco K; Bhattacharya S; Passi M; Ozkaya N; De Leon S; Chong S; Craft K; Diemer J; Bresciani E; O'Brien K; Andrews EJ; Park N; Hathaway L; Cowen EW; Heller T; Ryan K; Barochia A; Nghiem K; Niemela J; Rosenzweig S; Young DJ; Frischmeyer-Guerrerio PA; Braylan R; Liu PP
Blood; 2023 Dec; 142(25):2146-2158. PubMed ID: 37738626
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of safety and effectiveness between robotic and laparoscopic major hepatectomy: a systematic review and meta-analysis.
Mao B; Zhu S; Li D; Xiao J; Wang B; Yan Y
Int J Surg; 2023 Dec; 109(12):4333-4346. PubMed ID: 37720925
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of ultrasonographic images using a deep learning-based model as ancillary diagnostic tool for diagnosing gallbladder polyps.
Choi JH; Lee J; Lee SH; Lee S; Moon AS; Cho SH; Kim JS; Cho IR; Paik WH; Ryu JK; Kim YT
Dig Liver Dis; 2023 Dec; 55(12):1705-1711. PubMed ID: 37407319
[TBL] [Abstract] [Full Text] [Related]
15. Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling.
Kim DG; Yim SH; Min EK; Choi MC; Kim MS; Joo DJ; Lee JG
Liver Int; 2023 Sep; 43(9):2017-2025. PubMed ID: 37365992
[TBL] [Abstract] [Full Text] [Related]
16. cancer survival analysis and spatial distribution during 2014-2016 in Shandong Province, China.
Jiang F; Fu Z; Lu Z; Chu J; Xu A; Guo X; Ma J
Sci Rep; 2023 Jun; 13(1):10324. PubMed ID: 37365230
[TBL] [Abstract] [Full Text] [Related]
17. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
18. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
19. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
[TBL] [Abstract] [Full Text] [Related]
20. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).
Tinguely P; Ruiter SJS; Engstrand J; de Haas RJ; Nilsson H; Candinas D; de Jong KP; Freedman J
Eur J Cancer; 2023 Jul; 187():65-76. PubMed ID: 37119639
[TBL] [Abstract] [Full Text] [Related]
[Next]
